NESP Overdosage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Overdosage

Treatment of Overdosage: During the treatment with NESP, the hemoglobin concentration or the hematocrit level should be carefully monitored at regular intervals to prevent excessive hemopoiesis (hemoglobin concentration ≥12 g/dL, or hematocrit level ≥36%). If symptoms of excessive hemopoiesis develop, appropriate measures such as temporary discontinuation of NESP should be taken.

darbepoetin alfa

Manufacturer:

Kyowa Kirin

Distributor:

DKSH